Ordenar

Buscar

25/04/2025 Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review
Rodriguez-Antiguedad, J, Rajalingam, R, Krüger, C, Teixeira-dos-Santos, D, Sun, CSE, Fernandez-Toledo, E, Duarte, A, Saffie-Awad, P, Barrett, MJ, Flanigan, JL, Emamikhah, M, Patel, N, San Luciano, M, Cooper, C, Bahr, N, Oguh, O, Buhrmann, A, Vater, M, Fuchshofen, R, Vulinovic, F, Parreidt, MI, Weissbach, A, Lohmann, K, Klein, C, Marras, C, Camargos, S. Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(9)DOI:10.3390/ijms26094074. PMID:40362326. IF:4.900(Q1/3D).
22/04/2025 Clinical experience in open robotic-assisted microsurgery: user consensus of the European Federation of Societies for Microsurgery
Kueckelhaus, M, Nistor, A, van Mulken, T, Gazyakan, E, Dastagir, K, Wieker, H, Mani, M, Qiu, SS, Sorensen, JA, Pons, G, Vogt, P, Masia, J, Kneser, U, Tos, P, Suominen, S, Innocenti, M, Lindenblatt, N. Clinical experience in open robotic-assisted microsurgery: user consensus of the European Federation of Societies for Microsurgery. Journal of Robotic Surgery. 2025; 19(1)DOI:10.1007/s11701-025-02338-w. PMID:40263142. IF:3.000(Q1/2D).
22/04/2025 Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis
Zamora, C, Diaz-Torne, C, Ortiz, MA, Moya, P, Park, HS, Pitarch, C, Cantó, E, Osuna-Gomez, R, Mulet, M, Garcia-Arguinzonis, M, Collado, D, Corominas, H, Vidal, S. Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis. Cells. 2025; 14(9)DOI:10.3390/cells14090625. PMID:40358149. IF:5.200(Q2/3D).
19/04/2025 Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study
Idalsoaga, F, Diaz, LA, Dunn, W, Mehta, H, Caldentey, V, Arnold, J, Ayares, G, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Khan, MQ, Mortuza, R, Malhi, G, Islam, AH, Guizzetti, L, Ramirez-Cadiz, C, Cabezas, J, Echavarria, V, Poca, M, Cuyas, B, Soriano, G, Cots, MV, Higuera-De La Tijera, MF, Abraldes, JG, Al-Karaghouli, M, Skladany, L, Havaj, DJ, Rincón, D, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study. Egastroenterology. 2025; 3(2)DOI:10.1136/egastro-2024-100179. PMID:40276593. IF:(Q/D).
18/04/2025 Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol
Gutierrez-Gutierrez, G, Gomez-Ballesteros, R, Sotoca, J, Ares, A, Villaverde, R, Reyes, V, Armangue, T, Salas, E, Diaz-Abos, P, Rebollo, P, Sarmiento, M, Escobar, I, Maurino, J, Querol, L. Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. PLoS One. 2025; 20(4)DOI:10.1371/journal.pone.0322168. PMID:40261907. IF:2.600(Q2/4D).
18/04/2025 Evaluating the efficacy of radically open dialectical behavior therapy (RO-DBT) in patients with anorexia nervosa: study protocol for a randomized controlled clinical trial
Avila-Parcet, A, Martín-Blanco, A, Gawron, L, Cano, M, Peña-Arteaga, VD, Carceller-Sindreu, M, Soler, J, Portella, MJ, Faustino, G, Cardoner, N, Farrés, CCI. Evaluating the efficacy of radically open dialectical behavior therapy (RO-DBT) in patients with anorexia nervosa: study protocol for a randomized controlled clinical trial. BMC Psychiatry. 2025; 25(1)DOI:10.1186/s12888-025-06854-9. PMID:40251556. IF:3.600(Q1/3D).
18/04/2025 Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies
García-Aznar, JM, Besada-Cerecedo, ML, Castro-Alonso, C, Carpio, MS, Blasco, M, Quiroga, B, Cervienka, M, Mouzo, R, Torra, R, Ortiz, A, de Sequera, P. Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies. Genes. 2025; 16(4)DOI:10.3390/genes16040464. PMID:40282423. IF:2.800(Q2/5D).
18/04/2025 The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis
Zuellig, JA, Adam, R, Udry, F, Tibau, A, Seruga, B, Ocana, A, Amir, E, Templeton, AJ. The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. Cancers. 2025; 17(8)DOI:10.3390/cancers17081359. PMID:40282533. IF:4.400(Q2/3D).